Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer

Gynecologic Oncology

Volumn 106, Issue 2, 2007, Pages 388-393

  Rankins, N Calloway ^a   Secord, A Alvarez ^a   Jewell, E ^a   Havrilesky, L J ^a   Soper, J T ^a   Myers, E ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant radiotherapy; Cost effectiveness; Endometrial cancer; Intermediate risk endometrial cancer; Pelvic radiation

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; ENDOMETRIUM CANCER; FEMALE; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; SALVAGE THERAPY;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DECISION TREES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TREATMENT OUTCOME;

EID: 34447625747     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.04.015     Document Type: Article

References (22)

1. Hoskins W.J. Principles and practice of gynecologic oncology. 4th ed. (2005), Lippincott Williams and Wilkins, Philadelphia
2. Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92 3 (Mar 2004) 744-751
3. Creutzberg C.L. PORTEC2: Postoperative Radiation Therapy for Endometrial Carcinoma - a multicenter randomised phase III trial comparing external beam radiation and vaginal brachytherapy (2003). http://www.clinicalresearch.nl/portec2/PORTEC-2%20protocol-v03.pdf#search=%22PORTEC2%20oncology%22 cited; Protocol available from: http://www.clinicalresearch.nl/portec2/PORTEC-2%20protocol-v03.pdf#search=%22PORTEC2%20oncology%22
4. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355 9213 (Apr 22 2000) 1404-1411
5. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40 1 (Jan 1991) 55-65
6. Lee C.M., Szabo A., Shrieve D.C., Macdonald O.K., and Gaffney D.K. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 295 4 (Jan 25 2006) 389-397
7. Berman M.L. Adjuvant radiotherapy following properly staged endometrial cancer: what role?. Gynecol Oncol 92 3 (Mar 2004) 737-739
8. Laupacis A., Feeny D., Detsky A.S., and Tugwell P.X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 146 4 (Feb 15 1992) 473-481
9. Sears J.D., Greven K.M., Hoen H.M., and Randall M.E. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer 74 4 (Aug 15 1994) 1303-1308
10. Ackerman I., Malone S., Thomas G., Franssen E., Balogh J., and Dembo A. Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol 60 2 (Feb 1996) 177-183
11. Anderson J.M., Stea B., Hallum A.V., Rogoff E., and Childers J. High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys 46 2 (Jan 15 2000) 417-425
12. Chadha M., Nanavati P.J., Liu P., Fanning J., and Jacobs A. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 75 1 (Oct 1999) 103-107
13. Pearcey R.G., and Petereit D.G. Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. Radiother Oncol 56 1 (Jul 2000) 17-22
14. Barnes M.N., and Kilgore L.C. Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes. Semin Radiat Oncol 10 1 (Jan 2000) 3-7
15. Berclaz G., Hanggi W., Kratzer-Berger A., Altermatt H.J., Greiner R.H., and Dreher E. Lymphadenectomy in high risk endometrial carcinoma stage I and II: no more morbidity and no need for external pelvic radiation. Int J Gynecol Cancer 9 4 (Jul 1999) 322-328
16. Cragun J.M., Havrilesky L.J., Calingaert B., Synan I., Secord A.A., Soper J.T., et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23 16 (Jun 1 2005) 3668-3675
17. Huh W.K., Straughn Jr. J.M., Kelly F.J., and Kilgore L.C. Endometrial carcinoma. Curr Treatm Opt Oncol 2 2 (Apr 2001) 129-135
18. Kirby T.O., Leath III C.A., and Kilgore L.C. Surgical staging in endometrial cancer. Oncology (Williston Park) 20 1 (Jan 2006) 45-50 [discussion, 3-4, 63]
19. Larson D.M., Broste S.K., and Krawisz B.R. Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 91 3 (Mar 1998) 355-359
20. Mohan D.S., Samuels M.A., Selim M.A., Shalodi A.D., Ellis R.J., Samuels J.R., et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70 2 (Aug 1998) 165-171
21. Straughn Jr. J.M., Huh W.K., Kelly F.J., Leath III C.A., Kleinberg M.J., Hyde Jr. J., et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 84 2 (Feb 2002) 194-200
22. Kitchener H., Redman C.W., Swart A.M., and Amos C.L. ASTEC - a study in the treatment of endometrial cancer: a randomised trial of lymphadenectomy in the treatment of endometrial cancer. The 37th Annual Meeting on Women's Cancer™, Society of Gynecologic Oncologist (SGO); 2006 March 25, 2006; Palm Springs, CA (2006)